PH27122A - N-pyridinyl-9H-carbazol-9-amines and a process for their preparation - Google Patents

N-pyridinyl-9H-carbazol-9-amines and a process for their preparation Download PDF

Info

Publication number
PH27122A
PH27122A PH39801A PH39801A PH27122A PH 27122 A PH27122 A PH 27122A PH 39801 A PH39801 A PH 39801A PH 39801 A PH39801 A PH 39801A PH 27122 A PH27122 A PH 27122A
Authority
PH
Philippines
Prior art keywords
compound
hydrogen
pyridinyl
carbazol
formula
Prior art date
Application number
PH39801A
Other languages
English (en)
Inventor
Richard Charles Effland
Joseph Thomas Klein
Larry Davis
Gordon Edward Olsen
Original Assignee
Hoechst Rousell Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Rousell Pharmaceutical filed Critical Hoechst Rousell Pharmaceutical
Publication of PH27122A publication Critical patent/PH27122A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PH39801A 1988-12-27 1989-12-26 N-pyridinyl-9H-carbazol-9-amines and a process for their preparation PH27122A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/289,887 US4868190A (en) 1988-12-27 1988-12-27 N-pyridinyl-9H-carbazol-9-amines

Publications (1)

Publication Number Publication Date
PH27122A true PH27122A (en) 1993-03-16

Family

ID=23113557

Family Applications (1)

Application Number Title Priority Date Filing Date
PH39801A PH27122A (en) 1988-12-27 1989-12-26 N-pyridinyl-9H-carbazol-9-amines and a process for their preparation

Country Status (19)

Country Link
US (1) US4868190A (da)
EP (1) EP0376155B1 (da)
JP (1) JPH0725749B2 (da)
KR (1) KR900009596A (da)
AT (1) ATE79118T1 (da)
AU (1) AU623205B2 (da)
CA (1) CA2006529C (da)
DE (1) DE68902386T2 (da)
DK (1) DK662189A (da)
ES (1) ES2044043T3 (da)
FI (1) FI896243A7 (da)
GR (1) GR3006140T3 (da)
IE (1) IE894175L (da)
IL (1) IL92867A0 (da)
NO (1) NO895222L (da)
NZ (1) NZ231943A (da)
PH (1) PH27122A (da)
PT (1) PT92696A (da)
ZA (1) ZA899904B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
US4994472A (en) * 1989-08-02 1991-02-19 Hoechst-Roussel Pharmaceuticals Incorporated 1-(pyridinylamino)-2-pyrrolidinones as pain relievers
US5179099A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-dihydro-1-(pyridinylamino)-indoles
DK0415103T3 (da) * 1989-08-02 1995-06-19 Hoechst Roussel Pharma 2,3-Dihydro-1-(pyridinylamino)-indoler, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
US4983608A (en) * 1989-09-05 1991-01-08 Hoechst-Roussell Pharmaceuticals, Inc. N-substituted-4-pyrimidinamines and pyrimidinediamines
JP4189029B2 (ja) * 1995-07-27 2008-12-03 アベンティス・ファーマスーティカルズ・インコーポレイテッド 抗けいれん剤としての未置換および置換ｎ−（ピロール−１−イル）ピリジンアミンの使用
US5776955A (en) * 1995-07-27 1998-07-07 Hoechst Marion Roussel, Inc. Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents
ZA989365B (en) * 1997-10-15 1999-04-15 Boehringer Mannheim Pharm Corp Preparation for treating alzheimer's disease
PL365701A1 (en) * 2000-07-21 2005-01-10 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH475982A (de) * 1966-11-16 1969-07-31 Wander Ag Dr A Verfahren zur Herstellung von Carbazolderivaten
EP0073849A1 (en) * 1981-09-03 1983-03-16 Schering Corporation Novel phenyl-1,2,3,4-tetrahydrocarbazoles, their preparation and pharmaceutical compositions containing them
US4792562A (en) * 1985-12-04 1988-12-20 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing activity
US4752610A (en) * 1985-12-04 1988-06-21 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing properties
DE3852335T2 (de) * 1987-04-24 1995-05-11 Hoechst Roussel Pharma N-(Pyridinyl)-1H-indol-1-amine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel.
US4806554A (en) * 1988-01-11 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. Pyrazol and indazolpyridinamines
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
DK0415103T3 (da) * 1989-08-02 1995-06-19 Hoechst Roussel Pharma 2,3-Dihydro-1-(pyridinylamino)-indoler, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler

Also Published As

Publication number Publication date
NO895222D0 (no) 1989-12-22
AU4720389A (en) 1990-07-05
GR3006140T3 (da) 1993-06-21
EP0376155B1 (en) 1992-08-05
DE68902386T2 (de) 1993-02-11
ATE79118T1 (de) 1992-08-15
IE894175L (en) 1990-06-27
FI896243A0 (fi) 1989-12-22
ZA899904B (en) 1991-02-27
KR900009596A (ko) 1990-07-05
US4868190A (en) 1989-09-19
PT92696A (pt) 1990-06-29
FI896243A7 (fi) 1990-06-28
JPH02247173A (ja) 1990-10-02
IL92867A0 (en) 1990-09-17
EP0376155A1 (en) 1990-07-04
NZ231943A (en) 1992-06-25
ES2044043T3 (es) 1994-01-01
DK662189A (da) 1990-06-28
AU623205B2 (en) 1992-05-07
JPH0725749B2 (ja) 1995-03-22
DK662189D0 (da) 1989-12-22
CA2006529C (en) 1999-08-10
CA2006529A1 (en) 1990-06-27
NO895222L (no) 1990-06-28
DE68902386D1 (de) 1992-09-10

Similar Documents

Publication Publication Date Title
DE69233401T2 (de) Verbrückte zyklische polyamine mit anti-hiv wirkung
DE69831233T2 (de) Barbitursaure derivaten mit antimetastatischer und antitumorischer wirkung
SA99200064B1 (ar) مشتقات إيميدازو بيريدين imidazo pyridine المثبطة لإفراز الحمض المعدي acid secretion
EP0807629B1 (de) Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CZ253594A3 (en) Pharmaceutical composition for inhibiting proliferation of saponaceous muscle and restenosis
EP0887348A1 (en) Bis-Indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them
FI87648B (fi) Foerfarande foer framstaellning av terapeutiskt aktiv 8-halogen-11-(4-piperidyliden)-6,11-dihydro-5h-bentso/5,6/cyklohepta/1,2-b/-pyridin
DE68921298T2 (de) Herzschützende tocopherolähnliche Verbindungen.
IE922264A1 (en) Novel compounds
KR900006722B1 (ko) 항불안제
AU623098B2 (en) Esterified azacyclic hydroxy compounds
PH26080A (en) Novel antihypertensive benzopyran derivatives
EP0494754A1 (en) 3-hydroxypyridin-4-one derivatives as pharmaceutical compositions
RU2001126348A (ru) 4-гетероциклилсульфонамидил-6-метокси-5-(2-метоксифенокси)-2-пиридил пиримидиновые производные и фармацевтическая композиция
DE19706675A1 (de) Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US6767919B2 (en) High specificity anticancer agents
EP0376155B1 (en) N-pyridinyl-9h-carbazol-9-amines, a process for their preparation and their use as medicaments
DE60002395T2 (de) Metalloproteaseinhibitoren, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE3124673A1 (de) Subsituierte 2-amino-pyridinderivate, verfahren zu ihrer herstellung, ihre verwendung in arzneimitteln, sowie deren herstellung
KR20010034114A (ko) 칼륨 채널 활성화제
PL132131B1 (en) Process for preparing novel derivatives of 1,2,4-oxadiazolin-5-one
EP0110484B1 (en) Derivatives of aminopyridinecarboxylic acids, methods for their preparation and pharmaceutical compositions containing them
EP0660821B1 (en) Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors
KR20100066868A (ko) 신규한 2, 6-위치가 치환된 3-니트로피리딘 유도체 화합물, 이의 제조방법 및 이를 포함하는 약제학적 조성물
US4305938A (en) 2,8-Disubstituted-10-hydroxy-5,5-dimethyl-tetrahydro-and hexahydro-5H-[1]-benzopyrano[4,3-c]pyridines, compositions and use